Keywords: Merck & Co, Roche, Victrelis, Hepatitis C, Global promotion

Merck & Co expands collaboration with Roche on hep C drug Victrelis

Article | 21 July 2011

Print This

US drug giant Merck & Co (NYSE: MRK) has signed a new non-exclusive agreement with Swiss major Roche (ROG: SIX) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in